Childhood infections with human herpesviruses types 6, 7, and 8.
Grose
C
C
University of Iowa College of Medicine, Iowa City, USA.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000293:Adolescent; D000998:Antiviral Agents / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000209:etiology; D002490:Central Nervous System / Q000821:virology; D002648:Child; D002675:Child, Preschool; D005077:Exanthema Subitum / Q000209:etiology; D017245:Foscarnet / Q000627:therapeutic use; D015774:Ganciclovir / Q000627:therapeutic use; D016679:Genome, Viral; D006566:Herpesviridae Infections / Q000188:drug therapy / Q000209:etiology / Q000821:virology*; D015654:Herpesvirus 6, Human / Q000254:growth & development / Q000472:pathogenicity* / Q000648:ultrastructure; D016199:Herpesvirus 7, Human / Q000254:growth & development / Q000472:pathogenicity* / Q000648:ultrastructure; D019288:Herpesvirus 8, Human / Q000254:growth & development / Q000472:pathogenicity* / Q000648:ultrastructure; D006801:Humans; D012514:Sarcoma, Kaposi / Q000209:etiology / Q000821:virology; D014180:Transplantation / Q000009:adverse effects
D000998:Antiviral Agents; D017245:Foscarnet; D015774:Ganciclovir